2022 SNO Introduction to Clinical Trial Design and Protocol Development Workshop
Thursday, August 11, 2022
Now Being Held Virtually
Application Submission Closed
The Society for Neuro-Oncology is pleased to announce the 4th Annual Introduction to Clinical Trial Design and Protocol Development Workshop. This year’s workshop will be held virtually on Thursday, August 11, 2022, prior to the Conference on CNS Clinical Trials and Brain Metastases, Co-Sponsored by SNO and ASCO. New this year is an expanded offering to include an introductory protocol development option for participants without prior experience writing a clinical trial protocol or conducting clinical research.
As in the previous years, the 2022 workshop will address the essentials of effective clinical trial design in the treatment of CNS malignancies and focus on small group mentoring to provide tailored feedback to the participants. The overall objective is to provide guidance about the design, activation and conduct of clinical trials in neuro-oncology. These trials can span the adult and pediatric population and involve multidisciplinary modalities of treatment as well as non-therapeutic interventions related to biomarkers and quality of life. Participants will be mentored by faculty members with extensive experience in neuro-oncology clinical trials.
A total of up to 75 participants will be selected to attend the workshop through a competitive application process, with up to 50 participants selected for Group 1 and up to 25 participants selected for Group 2. Applicants will select their preferred Group in the application, but the Course Planning Committee reserves the right to make final Group selections for each participant.
- An introductory educational offering intended for trainees or junior faculty who have no prior experience writing clinical trial protocols or conducting clinical trials.
- Using small-group breakout sessions guided by faculty mentors, this track is meant to familiarize participants with the basic elements of developing a clinical trial protocol.
- Applicants do not need to have a specific clinical trial concept in mind upon applying to the workshop. However, following acceptance to the workshop, participants will be expected to identify an idea for a clinical trial that they will bring to the workshop for targeted discussion and feedback.
- Participants in Group 1 in 2022 will be encouraged to apply for Group 2 in 2023.
- This educational offering is intended for trainees or junior faculty who 1) already have a basic understanding of the key elements of clinical trial design and protocol writing and 2) have a specific clinical trial concept that they would like to further develop at the workshop.
- Scholars will work closely with their assigned mentors both before the actual workshop and during small-group breakout sessions to develop their concept into an actual clinical trial protocol. There will also be an opportunity for continued mentorship following the workshop.
- Applicants for this group must submit a synopsis of a specific clinical trial proposal with their application.
Upon completion of this course, participants will have an improved understanding of the practical aspects of CNS trials, including:
- Understanding the fundamentals of good trial design and protocol development,
- Understanding the scientific, statistical, regulatory, logistical and ethical aspects of CNS trials,
- Integrating correlative studies in CNS trials,
- Mitigating challenges to accrual and overcoming accrual barriers, and
- Anticipating the future direction of CNS trials.
Participation in the course is through a competitive application process and is open to clinical fellows, and junior clinical faculty (faculty must be within 7 years from first appointment) from all neuro-oncology subspecialties (neuro-oncology, medical oncology, radiation oncology, neurosurgery, pediatric oncology). Applications will also be considered from residents in neurology, radiation oncology, neurosurgery, internal medicine, and pediatrics if there is strong interest in a career in neuro-oncology. Applicants from traditionally underrepresented groups are strongly encouraged to submit applications. SNO membership (Full or Trainee Level) is required.
Upon completion of the course, all scholars will be provided with a certificate of completion from the Society for Neuro-Oncology. Please note, this is a one-time opportunity. If you have participated as a scholar in the past, you may not participate again.
Workshop Application Procedure
The online application procedure requires the following items to be received in the SNO administrative office by the application deadline of April 22, 2022:
- Statement of interest explaining why you wish to participate in this course.
- Your personal CV (pdf)
- Letter of support from your Program Supervisor or Department Head
- Brief clinical trial concept (Group 2 applicants only)
Notification of acceptance will be sent in May.
Scholarship Opportunity for International Applicants
The Society for Neuro-Oncology understands that brain tumors do not recognize geographical boundaries. SNO seeks to promote clinical and research activities in both pediatric and adult neuro-oncology in developing regions of the world. Travel scholarships to attend the 2022 Clinical Trial Design and Protocol Development Workshop will be awarded to two (2) international attendees from Low and Middle Income Countries (LMIC) as defined by the World Bank. For a list of eligible countries please click here.
In order to be considered for one of the Travel Scholarships, the applicant must meet the following guidelines:
- Work and live outside the United States or Canada
- Be a medical professional with a focus in neuro-oncology
- Has not previously received the scholarship for a past SNO meeting
- Could otherwise not attend without the benefit of a travel scholarship
- Have no visa issues entering the United States or Canada (SNO cannot provide visa assistance other than providing a letter of invitation)
- Complete Application for the 2022 Clinical Trials Workshop
Scholarship recipients will receive complimentary registration to both the Workshop and the Conference on CNS Clinical Trials and Brain Metastases, Co-Sponsored by SNO and ASCO, being held August 12-13, 2022 in Toronto, Canada; hotel accommodations; and a $1,500 stipend to be applied to costs associated with travel to the conference.
Registration will be open to all accepted applicants in May at $135 USD.
In addition, accepted Workshop participants will be able to register at the trainee rate for the 2022 Conference on CNS Clinical Trials and Brain Metastases
, an educational event jointly sponsored SNO and ASCO, being held August 12-13 at the same location in Toronto.
- Stephen Bagley, University of Pennsylvania
- Susan Chang, University of California, San Francisco
- Maryam Fouladi, Nationwide Children’s Hospital
- Mustafa Khasraw, Duke University
- Annette Molinaro, University of California, San Francisco
- Ian Parney, Mayo Clinic
- Vinay Puduvalli, University of Texas MD Anderson Cancer Center
- Erik Sulman, NYU Langone Medical Center
- Patrick Wen, Dana-Farber Cancer Institute